OCUTERRA
Live / Registered — Registered (as of 11 Jul 2023)
What this means for you
Registered since 11 Jul 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88739617
- Registration number
- 7108226
- Mark type
- Stylized text
- Filed
- 26 Dec 2019
- Published for opposition
- 28 Apr 2020
- Registered
- 11 Jul 2023
- Attorney of record
- Glenn A. Gundersen
Goods and services
- Class 005 — Pharmaceuticals: Ophthalmological preparations; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical products for ophthalmological use
Owner
- OCUTERRA THERAPEUTICS, INC., Boston, MA, US
- OCUTERRA THERAPEUTICS, INC., Boston, MA, US
- SciFluor Life Sciences, Inc., Boston, MA, US
- SciFluor Life Sciences, Inc., Boston, MA, US
Prosecution history
- 11 Jul 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Jul 2023 — REGISTERED-PRINCIPAL REGISTER
- 08 Jun 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Jun 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 May 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 May 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 May 2023 — ASSIGNED TO LIE
- 09 Feb 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Feb 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Feb 2023 — NON-FINAL ACTION E-MAILED
- 08 Feb 2023 — SU - NON-FINAL ACTION - WRITTEN
- 12 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jan 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Dec 2022 — USE AMENDMENT FILED
- 11 Jan 2023 — SOU EXTENSION 5 GRANTED